Co-op, R&D Chemistry: January - June 2027 (Onsite)
Insulet Corporation
Summary
This position will work in the chemistry lab and be trained and involved in the testing and analysis of body-worn drug delivery devices as it relates to biocompatibility and safety to the patient.
Job description
Responsibilities
- Use GCMS and conduct off gas analysis on Pod components with headspace autosampler.
- Use FTIR for investigation of foreign matter related to R&D, post market or manufacture.
- Use UPLC-MS to study extractable and leachable profiles of Pod.
- Coordinate sample submission to Contract labs.
- Author Test Protocol/Test Report for biocompatibility as needed.
- Help out/lighten other groups' workload as needed.
- Follow safety guidelines.
- Maintain electronic and/or paper notebooks.
- Author/Establish Tool Files for instruments/procedures in chemistry lab.
Required Skills and Competencies
- Highly ethical, responsible and data-driven decision-making methodology.
- Effective verbal and written communication skills.
- Ability to follow direction.
- Proficient in Microsoft Office Tools.
- Ability to work with chemistry-based lab equipment and tools.
Education and Experience
Currently pursuing a BS or BA in Chemistry, Chemical Engineering or a related field.
Requirements
- Currently pursuing a BS or BA in Chemistry, Chemical Engineering or a related field
- Highly ethical, responsible and data-driven decision-making methodology
- Effective verbal and written communication skills
- Ability to follow direction
- Proficient in Microsoft Office Tools
- Ability to work with chemistry-based lab equipment and tools
Benefits
- Medical Insurance
- Holiday Pay
- Sick Time Off
- Employee Wellness Programs
Company overview
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, founded in 2000 with a mission to improve the lives of people with diabetes. The company specializes in developing, manufacturing, and marketing the revolutionary Omnipod Insulin Management System, which provides a unique alternative to traditional insulin delivery methods. The Omnipod system features a tubeless, disposable wearable Pod that delivers up to three days of continuous insulin without the need for needles or tubing. Insulet's flagship product, the Omnipod 5 Automated Insulin Delivery System, integrates with continuous glucose monitors to manage blood sugar levels automatically, eliminating multiple daily injections and fingersticks. With operations spanning 25 countries across North America, Europe, the Middle East, and Asia Pacific, Insulet has established itself as a global leader in diabetes management technology. The company employs between 1,001-5,000 professionals dedicated to advancing diabetes care through innovative medical device solutions.